期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

成纤维细胞生长因子23与慢性肾脏病的进展 被引量：7

下载PDF
导出
摘要 慢性肾脏病（CKD）已成为威胁人类健康的重要疾病之一,临床研究表明大约有50%的CKD患者死于心血管疾病。高磷血症、高甲状旁腺激素（PTH）水平以及1,25（OH）2D3缺乏是CKD患者发生心血管事件以及死亡的独立危险因素。成纤维细胞生长因子23（FGF23）是一种调节血磷的激素,与很多磷代谢紊乱疾病的发病有关。
作者 曹娟
机构地区 扬州大学附属泰兴市人民医院肾内科
出处 《中国中西医结合肾病杂志》 2015年第5期468-470,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 高磷血症 甲状旁腺激素 磷代谢紊乱 心血管疾病 靶器官损伤 FGFR 血管钙化 肾脏病患者 肾脏保护 维持性透析
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献33

  • 1Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease:effects on the cardiovascular system. Circulation,2007,116( 1 ) : 85 - 97.
  • 2Tentori F, Blayney M J, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis,2008,52(3) :519 -530.
  • 3Seiler S, Heine GH, Fliser D. Clinical relevance of FGF23 in chronic kidney disease. Kidney Int Supp ,2009,114 : S34 - S42.
  • 4Wolf M. Fibroblast growth factor 23 and the future of phosphorus management. Curt Opin Nephrol Hypertens ,2009,18(6) :463 -468.
  • 5Michigami T. FGF23 and skeletal metabolism. Clinical Calcium, 2014,24(6) :879 -84.
  • 6Khosravi A, Cutler CM, Kelly MH, et al. Determination of the elimination hafflife of fibroblast growth factor 23. J Clin Endocri- nol Metab,2007,92 (6) : 2374 - 2377.
  • 7Liu S, Quarles LD. How fibroblast growth factor 23 works. J Am Soe Nephro1,2007,18 ( 6 ) : 1637 - 1647.
  • 8Urakawa I, Yamazaki Y, Shemada T, et al. Klotho converts canon- ical FGF receptor into a specific receptor for FGF23. Nature, 2006,444 (7120) :770 - 774.
  • 9Haruna Y, Kashihara N, Satoh M, et al. Amelioration of progres- sive renal injury by genetic manipulation of klotho gene. Proc Natl Acad Sci USA,2007,104 ( 7 ) :2331 - 2336.
  • 10Hu MC, Shi M, Quinones H, et al. Klotho deficiency is an early biomarker of renal ischemaia - reperfusion injury and its replace- ment is protective. Kidney Int,2010,78 (12) :1240- 1251.

二级参考文献9

  • 1Jean G,Terrat JC,Vanel T,et al.High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.Nephrol Dial Transplant,2009,24(9):2792-2796.
  • 2Gutierrez OM,Mannstadt M Isakova T,et al.Fibroblast growth factor 23 and motality among patients undergoing hemodialysis.N Engl J Med,2008,359(6):584-592.
  • 3Ramon I,Kleynen P,Body JJ,et al.Fibroblast growth factor 23 and its role in phosphate homeostasis.Eur J Endocrinol,2010,162(1):1-10.
  • 4Yokota H,Raposo JF,Chen A,et al.Evaluation of the Role of FGF23 in Mineral Metabolism.Gene Regul Syst Bio,2009,3:131-142.
  • 5Saito T,Fukumoto S.Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Merabolism.Int J Pediatr Endocrinol,2009,2009:496514.
  • 6Urakawa I,Yamazaki Y,Shimada T,et al.Klotho converts canonical FGF receptor into a specific receptor for FGF23.Nature,2006,444(7120):770-774.
  • 7Ibrahim S,Rashed L.Serum fibroblast growth factor-23 levels in chronic haemo dialysis patients.Int Urol Nephrol,2009,41(1):163-169.
  • 8Larsson TB.The role of FGF-23 in CKD-MBD and cardiovascular disease:Friend or foe?Nephrol Dial Transplant,2010,25(51):1376-1381.
  • 9Sigala F,Savvari P,Liontos M,et al.Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NFkappaB pathway.J Cell Mol Med,2010,doi:10.1111/j.1582-4934.2010.01082.

共引文献11

同被引文献42

引证文献7

二级引证文献16

中国中西医结合肾病杂志
2015年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部